Influence of a Calcium Phosphate Coating (BONIT®) on the Proliferation and Differentiation Potential of Human Mesenchymal Stroma Cells in the Early Phase of Bone Healing
Source abstract
Abstract
When implanting osteosynthetic materials or orthopedic implants, the surface condition plays a decisive role for mid- to long-term osseointegration. BONIT®, an electrochemically produced calcium phosphate (CaP) coating, has been used in the surface refinement of implants since 1995. More than 3.5 million coated implants have been successfully placed so far. BONIT® has thus been able to demonstrate clinical success. However, due to its surface properties and solubility, and the resulting difficulty in culturing cells, there are no in vitro studies investigating its influence at the molecular level, particularly on bone metabolism. In a first step, the cells from a total of ten donors were seeded separately on four different surfaces: 1. a pure corundum-blasted titanium surface (CELLTex®, CT), 2. CT with additional BONIT® coating (CT + B), 3. a hydroxyapatite-blasted titanium surface (DUOTex®, DT), 4. DT with additional BONIT® coating (DT + B). In a second step, the cells were grown for 48 h. The proliferation behavior and differentiation potential of hMSCs were investigated at three consecutive time points (12 h, 24 h and 48 h) by quantifying the mRNA expression of ten important differentiation markers using quantitative real-time polymerase chain reaction (qRT-PCR). We were able to show that BONIT® has an influence on the early proliferation and differentiation behavior of hMSCs in patients of all age groups. The additional BONIT® coating on CELLTex® or DUOTex® led to a defined mRNA expression pattern for the investigated factors: a tendency towards a higher expression rate with coating present could be found for bone morphogenetic protein 2 (BMP2), osteopontin (OPN), osteocalcin (OC), receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG). A similar or lower expression rate was detected for runt-related transcription factor 2 (RUNX2), alpha-1 type I collagen (COL1A1), alkaline phosphatase (AP), osteonectin (ON) and insulin-like growth factor I (IGF1). We have developed a new method that allows the cultivation of human mesenchymal stromal cells (hMSCs) on the soluble coating BONIT® for gene expression analysis. BONIT® has a significant influence on the proliferation and differentiation behavior of human mesenchymal stroma cells. This study describes a defined gene expression pattern of bone metabolism that may help to understand the influence of this CaP coating on the early phase of implant osseointegration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Clinic for Orthopaedic Surgery, Heinrich-Heine-University, Moorenstraße 5, 40225 Düsseldorf, Germany
Department of Arthroscopy and Endoprosthetics, Krankenhaus Nettetal GmbH, Sassenfelder Kirchweg 1, 41334 Nettetal, Germany
Clinic for Orthopaedic Surgery, St. Marien-Hospital Mülheim an der Ruhr, Kaiserstraße 50, 45468 Mülheim an der Ruhr, Germany
Orthopaedics, Trauma and Reconstructive Surgery, University of Duisburg-Essen, Forsthausweg 2, 47057 Duisburg, Germany
References (100+)
Show source-provided references
1. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: A systematic review
2. Risk factors for revision of primary total hip arthroplasty: A systematic review
3. The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases10.1007/s10067-014-2841-6 ↗
4. Reflecting on the global burden of musculoskeletal conditions: Lessons learnt from the Global Burden of Disease 2010 Study and the next steps forward10.1136/annrheumdis-2014-205393 ↗
5. (2019, October 09). Krankheitskosten—Krankheitskosten Einrichtungen Deutschland. Available online: http://www.gbe-bund.de.
6. Institut für Sozialmedizin, Epidemiologie und Gesundheitssystemforschung, Hannover (2010). BARMER GEK Report Krankenhaus, Asgard-Verlag. vol. Schriftenreihe zur Gesundheitsanalyse, Band 3.
7. National Institute for Health and Care Excellence (2014). Total Hip Replacement and Resurfacing Arthroplasty for End-Stage Arthritis of the Hip/Technology Appraisal Guidance [TA304], NICE.
8. (ii) Biomechanics of implant fixation10.1016/j.mporth.2013.02.004 ↗
9. In vivo behaviour of hydroxyapatite coatings on titanium implants: A quantitative study in the rabbit10.1016/S0142-9612(01)00392-1 ↗
10. Claes, L., Kirschner, P., Perka, C., and Rudert, M. (2012). AE-Manual der Endoprothetik/Hüfte und Hüftrevision, Springer.10.1007/978-3-642-14646-6 ↗
11. Wirtz, D.C. (2011). AE-Manual der Endoprothetik/Knie, Springer.10.1007/978-3-642-12889-9 ↗
12. Wintermantel, E., and Ha, S.-W. (2009). Medizintechnik: Life Science Engineering, Springer Science & Business Media.10.1007/978-3-540-93936-8 ↗
13. Kastilan, S. (2000). Bioverträgliche Oberflächen für Implantate und Prothesen. Die Welt, Available online: https://www.welt.de/print-welt/article530246/Biovertraegliche-Oberflaechen-fuer-Implantate-und-Prothesen.html.
14. Entwicklung biokeramischer Beschichtungen für Hüft-Endoprothesen (Teil 1)
15. Nöbel, D. (2007). Untersuchungen zur Osteointegration und Resorbierbarkeit von Implantatbeschichtungen für den Knochenersatz-Eine histologische und histomorphometrische Studie am Tiermodell. [Ph.D. Thesis, Leipzig University].
16. The material science of calcium phosphate ceramics10.1016/0142-9612(80)90009-5 ↗
17. Review: Zirconia as a ceramic biomaterial10.1016/S0142-9612(98)00010-6 ↗
18. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle10.1002/jbm.820070304 ↗
19. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs10.1002/jbm.820250708 ↗
20. Entwicklung biokeramischer Beschichtungen für Hüftendoprothesen (Teil 2)
21. DOT GmbH (2019, November 09). Schnelleres Einheilen Durch Die Elektrochemische Calciumphosphat-Beschichtung BONIT (R). Available online: https://www.dot-coating.de/images/pdf/beschichtungen/ortho/Elektrochemische-Calciumphosphat-Beschichtung-BONIT.pdf.
22. Evaluation of BONIT®, a Fully Resorbable CaP Coating Obtained by Electrochemical Deposition, after 6 Weeks of Healing: A Pilot Study in the Pig Maxilla
23. Resorbable Calcium Phosphate Composite Coatings10.4028/www.scientific.net/KEM.218-220.653 ↗
24. Hegenbarth, A. (2009). Modifizierung der Oberfläche von Implantaten zur Optimierung der Osseointegration—Charakterisierung von Herstellungsverfahren und Schichteigenschaften. [Bachelor’s Thesis, Fachhochschule Osnabrück].
25. The transcortical Göttingen Minipig model for testing osteointegration of implant surfaces and the influence of a soluble CaP coating on osteointegration10.1016/S0021-9290(06)82907-6 ↗
26. Effect of a resorbable CaP coating on bone-implant contact and density in a gap model after 4 weeks and 8 weeks. An experimental study in Göttinger Minipigs10.1016/S0021-9290(06)82907-6 ↗
27. Tschofen, S. (2018). Osseointegration von Nanokristallinen Diamantoberflächen, Zirkonoxid und Kalziumphosphat im Schafstibiamodell. [Diploma Thesis, Medizinische Universität Innsbruck, Universitätsklinik für MKG-Chirurgie].
28. Different patterns of bone fixation with hydroxyapatite and resorbable CaP coatings in the rabbit tibia at 6, 12, and 52 weeks10.1002/jbm.b.31866 ↗
29. A biphasic calcium phosphate coating for potential drug delivery affects early osseointegration of titanium implants10.1111/jop.12464 ↗
30. Vertical Osteoconductive Characteristics of Titanium Implants with Calcium-Phosphate-Coated Surfaces—A Pilot Study in Rabbits10.1111/j.1708-8208.2012.00469.x ↗
31. Immediately Loaded FBR-Coated Pitt-Easy Bio-Oss Implants. A Histologic evaluation in 3 Patients after 8–12 Weeks of Function
32. SB Charité Disc Replacement: Report of 60 Prospective Randomized Cases in a U.S. Center10.1097/00024720-200308000-00016 ↗
33. DOT GmbH (2015). Schichtdossier BONIT(R) Orthopädische Anwendungen, DOT GmbH.
34. Hentschel, M. (2013). Dissertation: Untersuchung von Vorläuferzellen in Abhängigkeit von Dekorierten, Sowie Nicht Dekorierten Implantatoberflächen als Wachstumsunterlage, Ernst-Moritz-Arndt-Universität.
35. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
36. Pilge, H., Fröbel, J., Mrotzek, S.J., Fischer, J.C., Prodinger, P.M., Zilkens, C., Bittersohl, B., and Krauspe, R. (2016). Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: An in-vitro study comparing enoxaparin with rivaroxaban. BMC Musculoskelet. Disord., 17.10.1186/s12891-016-0966-2 ↗
37. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method10.1006/meth.2001.1262 ↗
38. Targeting Early Healing Phase with Titania Nanotube Arrays on Tunable Diameters to Accelerate Bone Regeneration and Osseointegration10.1002/smll.202006287 ↗
39. Junqueira, L.C., and Jose, C. (2002). Basic Histology: Text und Atlas, McGraw-Hill/Appleton&Lang.
40. Hydroxyapatite-coated titanium for orthopedic implant applications10.1097/00003086-198807000-00030 ↗
41. Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies10.1016/j.mser.2009.05.001 ↗
42. Die biologische und medizinische Bedeutung von Calciumphosphaten10.1002/1521-3757(20020902)114:17<3260::AID-ANGE3260>3.0.CO;2-S ↗
43. Ergebnisse nach zementfrei implantierten Femurschaftendoprothesen vom Modell Hofheim nach einer Laufzeit von 10 Jahren
44. Zervikaler Bandscheibenersatz. Die PCM-Zwischenwirbel-Endoprothese
45. Die Metha-Kurzschaftprothese
46. 5-Jahres-Ergebnisse einer modernen Pressfit-Pfanne
47. Multilineage Potential of Adult Human Mesenchymal Stem Cells10.1126/science.284.5411.143 ↗
48. Pluripotency of mesenchymal stem cells derived from adult marrow10.1038/nature00870 ↗
49. Notch signaling in osteoblasts10.1126/stke.117pe17 ↗
50. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair10.1016/j.bone.2010.03.012 ↗
51. Osteoblast Differentiation at a Glance10.12659/MSMBR.901142 ↗
52. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development10.1016/S0092-8674(00)80259-7 ↗
53. Signaling and transcriptional regulation in osteoblast commitment and differentiation10.2741/2296 ↗
54. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation10.1016/S0092-8674(00)80257-3 ↗
55. Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts
56. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts10.1016/S0092-8674(00)80258-5 ↗
57. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes10.1074/jbc.M006215200 ↗
58. (2019, September 14). COL1A1 Collagen Type I alpha 1 Chain [Homo Sapiens (Human)]-Gene-NCBI. NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/1277.
59. Collagens: Molecular biology, diseases, and potentials for therapy10.1146/annurev.bi.64.070195.002155 ↗
60. The family of collagen genes10.1146/annurev.bi.59.070190.004201 ↗
61. Bone Injury and Fracture Healing Biology
62. The Influence of Type I Collagen on the Development and Maintenance of the Osteoblast Phenotype in Primary and Passaged Rat Calvarial Osteoblasts: Modification of Expression of Genes Supporting Cell Growth, Adhesion, and Extracellular Matrix Mineralization10.1006/excr.1995.1005 ↗
63. Osseointegration and its experimental background10.1016/S0022-3913(83)80101-2 ↗
64. Osseointegrated Titanium Implants: Requirements for Ensuring a Long-Lasting, Direct Bone-to-Implant Anchorage in Man10.3109/17453678108991776 ↗
65. Perspectives in alkaline phosphatase research10.1093/clinchem/38.12.2486 ↗
66. McComb, R.B., Bowers, G.N., and Posen, S. (1979). Alkaline Phosphatase, Plenum Press.10.1007/978-1-4613-2970-1 ↗
67. The human alkaline phosphatases: What we know and what we don’t know10.1016/0009-8981(90)90031-M ↗
68. Diverse biological functions of the SPARC family of proteins10.1016/j.biocel.2011.12.021 ↗
69. Revisiting the matricellular concept10.1016/j.matbio.2014.07.005 ↗
70. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling10.1007/s12079-009-0076-0 ↗
71. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity10.1074/jbc.M504663200 ↗
72. Osteonectin, a bone-specific protein linking mineral to collagen10.1016/0092-8674(81)90037-4 ↗
73. Sequence of cDNA encoding human insulin-like growth factor I precursor10.1038/306609a0 ↗
74. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I10.1074/jbc.M313201200 ↗
75. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues10.1152/ajpendo.00159.2005 ↗
76. Leprechaunism10.1136/adc.30.154.479 ↗
77. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: Differential signalling via Akt and ERK10.1002/cbf.2801 ↗
78. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family10.1002/j.1460-2075.1990.tb07376.x ↗
79. Novel regulators of bone formation: Molecular clones and activities10.1126/science.3201241 ↗
80. Bone: Formation by Autoinduction10.1126/science.150.3698.893 ↗
81. Bone Morphogenetic Protein10.1177/00220345710500060601 ↗
82. Meyer, R.A., Meyer, M.H., Phieffer, L.S., and Banks, D.M. (2001). Delayed union of femoral fractures in older rats:decreased gene expression. BMC Musculoskelet. Disord., 2.10.1186/1471-2474-2-2 ↗
83. Overview of the fracture healing cascade10.1016/j.injury.2005.07.027 ↗
84. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-210.1002/jcp.10166 ↗
85. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin10.1038/nature01245 ↗
86. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage10.1083/jcb.127.6.1755 ↗
87. Signal transduction of bone morphogenetic proteins in osteoblast differentiation10.2106/00004623-200300003-00007 ↗
88. Osteopontin: A protein with diverse functions10.1096/fasebj.7.15.8262332 ↗
89. Osteopontin overview10.1111/j.1749-6632.1995.tb44614.x ↗
90. Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo10.1359/jbmr.2003.18.9.1706 ↗
91. Role of osteopontin in modulation of hydroxyapatite formation10.1007/s00223-013-9698-6 ↗
92. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel10.1016/S0169-6009(08)80225-5 ↗
93. Gressner, A.M., and Arndt, T. (2019). Lexikon der Medizinischen Laboratoriumsdiagnostik, Springer.10.1007/978-3-662-48986-4 ↗
94. Osteocalcin: Isolation, characterization, and detection10.1016/0076-6879(84)07036-1 ↗
95. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone10.1002/ar.1092240208 ↗
96. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin10.1016/S8756-3282(98)00092-1 ↗
97. The effect of Gla-containing proteins on the precipitation of insoluble salts10.1016/0006-291X(87)90458-X ↗
98. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment10.1073/pnas.79.24.7734 ↗
99. Dilatational band formation in bone10.1073/pnas.1201513109 ↗
100. NMR investigation of the role of osteocalcin and osteopontin at the organic-inorganic interface in bone10.1021/la403203w ↗